The stock's fall snapped a two-day winning streak.

Shares of Boston Scientific Corp. BSX advanced 1.53% to $100.88 Monday, on what proved to be an all-around favorable trading ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Boston Scientific Co. (NYSE:BSX – Get Free Report) has been assigned an average recommendation of “Buy” from the twenty-three research firms that are presently covering the stock, MarketBeat.com ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is willing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.